Бесплатно (1) 30 мл Бактериостатическая вода
с квалифицированными заказами более $500 доллар США.
(исключает капсульные продукты, косметические пептиды, промокоды и доставка)
Hexarelin is a synthetic analogue of ghrelin that shows benefit in heart disease and cardiac ischemia, protecting the heart following heart attack. Research has shown that Hexarelin also protects skeletal muscle against wasting and improves cholesterol and triglyceride levels.
Использование продукта: НАСТОЯЩИЙ ПРОДУКТ ПРЕДНАЗНАЧЕН ТОЛЬКО В качестве ИССЛЕДОВАТЕЛЬСКОГО ХИМИКАТА.. Это обозначение позволяет использовать исследовательские химикаты исключительно для испытаний in vitro и лабораторных экспериментов.. Вся информация о продуктах, доступная на этом сайте, предназначена только для образовательных целей.. Телесное введение любого вида в организм человека или животного строго запрещено законом.. С этим продуктом должны обращаться только лицензированные, квалифицированные специалисты. Этот продукт не является лекарством, еда, или косметическое средство и не может иметь неверную маркировку, неправильно использовался или ошибочно маркировался как наркотик, еда или косметика.
What Is Hexarelin?
Hexarelin Structure
Источник: PubChem
Последовательность: His-D-Trp(2-Me)-Ala-Trp-D-Phe-Lys
Молекулярная формула: С47ЧАС58Н12О6
Молекулярная масса: 887.059 г/моль
ПабХим CID:6918297
Количество CAS: 140703-51-1
Hexarelin Effects
1. Protects the Heart
Hexarelin directly affects the heart by binding to the CD36 receptor and the growth hormone secretagogue receptor (GHSR). Studies in mice suggest hexarelin protects heart cells from injury in the setting of heart attack by binding to these receptors and preventing cells from undergoing apoptosis (запрограммированная гибель клеток). Mice treated with hexarelin in this study showed improved heart function, increased number of surviving heart cells, and decreased production of malondialdehyde (a marker of heart cell death). интересно, GHRP-6 was found to be slightly superior to ghrelin in this study[1], [2].
A study in rats investigating the ability of GHRP-6 to offset problems associated with heart failure found that the peptide reduces oxidative stress in heart failure and prevents myocardial remodeling from taking place. Remodeling is a pathological process associated with a decline in heart function and serious morbidity. Rats treated with GHRP-6 in this study had significant improvements in the function of their heart. These processes are thought to be mediated by GHRP-6 up-regulation of phosphatase and tensin homologue (PTEN) activity as well as down regulation of protein kinase B expression[3]. PTEN plays a role in cell regeneration while protein kinase B regulates cell survival.
GHRP-6 is so effective in reducing cardiac remodeling that it shifts the balance of nervous system activity away from sympathetic stimulation (higher heart rate, higher blood pressure, и т. д.) toward parasympathetic dominance. This not only improves short-term health and outcomes, but reduces the need for medication over the long term and likely helps to prevent cardiac remodeling that is secondary to increased stress on the heart. Rats treated with GHRP-6 following a heart attack show substantial reductions in the size of the scar left behind[4], [5].
Size of damage following heart attack at 24 hours and 14 days in rats treated with standard care or standard care plus hexarelin.Источник: ПабМед
Because the mechanism by which hexarelin protects heart cells is not specific to the mechanism of damage in heart attack, researchers speculated that the peptide could be used to protect the heart from other insults as well. Исследовать, again in rats, found that hexarelin improved cardiac function in a model of diabetes by changing the way calcium and potassium are processed by heart muscle cells[6]–[8].
Diagram showing progression to serious long-term disease following heart attack. Blue ovals indicate how hexarelin interferes with this pathway.Источник: ПабМед
2. Improves Fat Measures
Dyslipidemia refers to an abnormal amount of fat in the blood. интересно, dyslipidemia is an independent risk factor for the development of diabetes, even in thin and outwardly healthy individuals. Фактически, dyslipidemia may help to explain the current diabetes crisis in first-world nations and understanding its effects on human physiology is paramount to combating the growing health concerns associated with modern diets. Research in rats indicates that GHRP-6 can correct dyslipidemia in the setting of insulin resistance (the first step in the pathway to diabetes) while simultaneously lowering blood sugar and insulin resistance[9]. The peptide may offer an alternative to current lipid medications for the treatment of severe dyslipidemia.
3. Protects Muscle
It isn’t just heart muscle that hexarelin protects. Studies in rat models of cachexia (extreme weight loss due to illness or chemotherapy) indicate that GHRP-6 protects muscle cells by regulating calcium flow as well as mitochondrial dysfunction[10]. Mitochondria are the power plants of cells. Without them, cells cannot produce the energy they need to carry out normal function and will eventually die.
Calcium regulation is often disrupted by chemotherapy. Calcium dysregulation is one of the primary reasons that muscle mass and lean body mass are affected during cancer treatment. Research in rats indicates GHRP-6 offsets the alterations in calcium regulation caused by chemotherapy[11].
А. Mitochondrial DNA content relative to controlБ. Content of MCH1 and MHC2A mRNA
С. Protein content of of muscle cells relative to controlled
Источник: ПабМед
Hexarelin Heavily Researched
Heart disease is the leading cause of death in most developed nations. Understanding the complex process that leads to heart disease, сердечная недостаточность, and eventually death is not easy, but scientists are beginning to unravel the mystery with help from peptides like hexarelin. Research utilizing hexarelin has revealed a number of new pathways for understanding the function of the heart in health and disease. It has also opened the door to develop new treatments for problems, like cardiac remodeling, that have proved difficult to treat in the past.
Hexarelin exhibits moderate side effects, низкая биодоступность при пероральном приеме и отличная подкожная биодоступность у мышей. Дозировка на кг для мышей не масштабируется для людей.. Hexarelin for sale at
Автор статьи
Вышеуказанная литература была исследована, отредактировано и организовано доктором. Логан, доктор медицинских наук. Доктор. Логан получил докторскую степень в Медицинский факультет Университета Кейс Вестерн Резерв и степень бакалавра наук. в молекулярной биологии.
Автор научного журнала
Aline Moulin’s research while affiliated with French National Centre for Scientific Research and other places are extensive. She is well versed in pharmaceutical development, management, external manufacturing operations, quality control, regulatory control, drug delivery, and drug discovery research. She has used Hexarelin in multiple studies to monitor if certain pharmaceuticals were capable of inhibiting many of its effects.
Aline Moulin’s is being referenced as one of the leading scientists involved in the research and development of Hexarelin. Ни в коем случае этот врач/ученый не одобряет и не пропагандирует покупку, распродажа, или использование этого продукта по любой причине. Нет никакой принадлежности или родства, подразумеваемый или иной, между
Ссылочные цитаты
- Дж. Huang, Да. Ли, Дж. Чжан, Да. Лю, and Q. Lu, “The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway,» Инт. Heart. Дж., том. 58, нет. 2, пп. 257–263, апрель. 2017.
- Да. Mao et al., “Hexarelin treatment in male ghrelin knockout mice after myocardial infarction,Эндокринология, том. 154, нет. 10, пп. 3847–3854, октябрь. 2013.
- Э. Agbo et al., “Modulation of PTEN by hexarelin attenuates coronary artery ligation-induced heart failure in rats,” Turk. Дж. С. наук., том. 49, нет. 3, Может 2019.
- ЧАС. McDonald et al., “Hexarelin treatment preserves myocardial function and reduces cardiac fibrosis in a mouse model of acute myocardial infarction,Физиол. Представитель, том. 6, нет. 9, п. e13699, 2018.
- Икс. Сюй и др., “Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously hypertensive rat," Являюсь. Дж. Физиол. Heart Circ. Физиол., том. 303, нет. 6, пп. H703-711, Сентябрь. 2012.
- Икс. Чжан, л. Qu, л. Чен, и С. Чен, “Improvement of cardiomyocyte function by in vivo hexarelin treatment in streptozotocin-induced diabetic rats,Физиол. Представитель, том. 6, нет. 4, 2018.
- Да. Мао, Т. Tokudome, я. Kishimoto, К. Otani, М. Miyazato, и К. Kangawa, “One dose of oral hexarelin protects chronic cardiac function after myocardial infarction,” Peptides, том. 56, пп. 156–162, июнь. 2014.
- Да. Ма, л. Чжан, Дж. Н. Edwards, Б. С. Launikonis, и С. Чен, “Growth hormone secretagogues protect mouse cardiomyocytes from in vitro ischemia/reperfusion injury through regulation of intracellular calcium,ПлоС Один, том. 7, нет. 4, п. e35265, 2012.
- р. Mosa et al., “Hexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in Nonobese Insulin-Resistant Male MKR Mice,Эндокринология, том. 158, нет. 10, пп. 3174–3187, 01 2017.
- г. Sirago et al., “Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia,» Наука. Представитель, том. 7, октябрь. 2017.
- Э. Conte et al., “Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia,» Дж.. Cachexia Sarcopenia Muscle, том. 8, нет. 3, пп. 386–404, июнь. 2017.
- Torsello, Antonio & Bresciani, Elena & Tamiazzo, Laura & Bulgarelli, Ilaria & Caporali, Simona & Moulin, Aline & Fehrentz, jean-alain & Martinez, Jean & Perissoud, Daniel & Locatelli, Vittorio. (2008). Novel potent and selective non-peptide ligands of ghrelin receptor : characterization of endocrine and extraendocrine actions.
ВСЕ СТАТЬИ И ИНФОРМАЦИЯ О ПРОДУКЦИИ, ПРЕДОСТАВЛЕННЫЕ НА ЭТОМ ВЕБ-САЙТЕ, ПРЕДНАЗНАЧЕНЫ ТОЛЬКО ДЛЯ ИНФОРМАЦИОННЫХ И ОБРАЗОВАТЕЛЬНЫХ ЦЕЛЕЙ..
Продукты, предлагаемые на этом сайте, предназначены только для исследований in vitro.. Исследования in vitro (латинский: в стекле) выполняются вне тела. Эти продукты не являются лекарствами или лекарствами и не были одобрены FDA для предотвращения, лечить или вылечить любое заболевание, недуг или болезнь. Телесное введение любого вида в организм человека или животного строго запрещено законом..